Voss Capital, LP - 31 Dec 2025 SCHEDULE 13G/A Report for Rein Therapeutics, Inc. Common Stock, $0.001 par value (RNTX)

Filing Manager
Voss Capital, LP
Reporting Manager
Voss Capital, LP
Security
Rein Therapeutics, Inc. Common Stock, $0.001 par value
Symbol
RNTX
Shares outstanding
26,288,053 shares
Disclosed Ownership
4,468,969 shares
Ownership
17%
Form type
SCHEDULE 13G/A
Filing time
13 Feb 2026, 16:15:26 UTC
Date of event
31 Dec 2025
Previous filing
26 Sep 2025
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"Voss Capital, LP disclosed 17% ownership in Rein Therapeutics, Inc. Common Stock, $0.001 par value (RNTX) on 31 Dec 2025."

Quick Takeaways

  • Voss Capital, LP filed SCHEDULE 13G/A for Rein Therapeutics, Inc. Common Stock, $0.001 par value (RNTX).
  • Disclosed ownership: 17%.
  • Date of event: 31 Dec 2025.

What Changed

  • Previous schedule filing date: 26 Sep 2025.
  • Current filing was accepted on 13 Feb 2026, 16:15.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (5)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Voss Value Master Fund, LP 3.5% 926,441 926,441 0 /s/ Travis W. Cocke Travis W. Cocke, Managing Member of Voss Advisors GP, LLC, its General Partner
Voss Value-Oriented Special Situations Fund, LP 1.9% 500,000 500,000 0 /s/ Travis W. Cocke Travis W. Cocke, Managing Member of Voss Advisors GP, LLC, its General Partner
Voss Advisors GP, LLC 5.4% 1,426,441 1,426,441 0 /s/ Travis W. Cocke Travis W. Cocke, Managing Member
Voss Capital, LP 17% 4,468,969 3,776,484 692,485 /s/ Travis W. Cocke Travis W. Cocke, Managing Member
Cocke Travis W. 17% 4,468,969 3,776,484 692,485 /s/ Travis W. Cocke Travis W. Cocke

Sponsored